Mutational Landscape of Cancer-Driver Genes Across Human Cancers
Abstract
The cancer driver genes are involved in transforming healthy cells into cancerous cells. The molecular aberrations which lead to cancer involve gain and loss of function mutations in various cancer driver genes. Here, we examine the genome sequences of 20,066 primary tumours representing 43 distinct human cancers to identify and catalogue driver mutations in 729 known cancer genes. We show that the frequency of driver mutations in these genes varies significantly between cancer types. We find that the class of cancer driver genes most frequently mutated are the tumour suppressor genes (94%), followed by oncogenes (93%), transcription factors (72%), kinases (64%), cell surface receptors (63%), and phosphatases (22%). Furthermore, we identify the subset of these genes within which mutations exhibit a co-occurrence or mutually exclusive pattern. Interestingly, we find that patients with tumours with different combinations of driver gene mutation patterns tend to exhibit variable survival outcomes. Here, among the well-studied cancer genes, we showed that patients with tumours with KRAS and TP53 mutations are associated with the worst disease outcomes, and those with PI3KCA and BRAF mutations are associated with favourable survival outcomes. Besides providing new insights into cancer driver mutations, we unearth mutation patterns associated with disease outcomes and various hallmarks of cancer that bring us closer to fully understanding various forms of cancer.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 124
- FWCI
- 15.71
- Field percentile
- top 1%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Mutation bias in driver genes reveals the distribution of effects of oncogenic mutations
Anastasia V. Stolyarova, Georgii A. Bazykin·bioRxiv·Sep 25, 2025
- In silico saturation mutagenesis of cancer genes
F. Muinos, F. Martinez-Jimenez, … N. Lopez-Bigas·bioRxiv·Jun 3, 2020
- The whole-genome panorama of cancer drivers
Radhakrishnan Sabarinathan, Oriol Pich, … on behalf of the PCAWG Drivers and Functional Interpretation Group and the ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Network·bioRxiv·Dec 23, 2017
- The cancer-mutation network and the number and specificity of driver mutations
J. Iranzo, I. Martincorena, E. V. Koonin·bioRxiv·Dec 19, 2017
- Finding Driver Mutations in Cancer: Elucidating the Role of Background Mutational Processes
A.-L. Brown, M. Li, … A. R. Panchenko·bioRxiv·Apr 1, 2019
- The cumulative impact of passenger mutations on cancer development
Akshatha Nayak, Candace S. Y. Chan, … Ilias Georgakopoulos‐Soares·Nature CommunicationsPeer-reviewed·Jun 4, 2026